EDGAR Filer Form List
CIK: 0001646303
Form Type:
Year
| Form | Subject Company | Description | Filing Agent | Date | Actions | ||
|---|---|---|---|---|---|---|---|
| 424B2 | Morgan Stanley | Prospectus filed pursuant to Rule 424(b)(2) | Quality Edgar - Qes /fa | 07/13/2026 | |||
| 424B2 | Morgan Stanley Finance Llc | Prospectus filed pursuant to Rule 424(b)(2) | Quality Edgar - Qes /fa | 07/13/2026 | |||
| S-8 POS | Esperion Therapeutics, Inc. | Post-effective amendment to a S-8 regist... | Toppan Merrill/fa | 07/13/2026 | |||
| S-8 POS | Esperion Therapeutics, Inc. | Post-effective amendment to a S-8 regist... | Toppan Merrill/fa | 07/13/2026 | |||
| 13F-HR | Perennial Advisors, Llc | Initial Quarterly Form 13F Holdings Repo... | 07/13/2026 | ||||
| S-8 POS | Esperion Therapeutics, Inc. | Post-effective amendment to a S-8 regist... | Toppan Merrill/fa | 07/13/2026 | |||
| FWP | Bank Of America Corp /de/ | Filing under Securities Act Rules 163/43... | Wallstreetdocs Ltd /fa | 07/13/2026 | |||
| 424B2 | Bank Of America Corp /de/ | Prospectus filed pursuant to Rule 424(b)(2) | Wallstreetdocs Ltd /fa | 07/13/2026 | |||
| 424B2 | Bofa Finance Llc | Prospectus filed pursuant to Rule 424(b)(2) | Wallstreetdocs Ltd /fa | 07/13/2026 | |||
| S-8 POS | Esperion Therapeutics, Inc. | Post-effective amendment to a S-8 regist... | Toppan Merrill/fa | 07/13/2026 | |||
| Load More | |||||||
